These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9820055)

  • 21. Effect of ramipril therapy on cognitive functions in cases of mild to moderate essential hypertension.
    Qureshi N; Babbar R
    Indian J Physiol Pharmacol; 2007; 51(1):40-8. PubMed ID: 17877291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
    Schrader J; Lüders S; Kulschewski A; Hammersen F; Züchner C; Venneklaas U; Schrandt G; Schnieders M; Rangoonwala B; Berger J; Dominiak P; Zidek W;
    J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of ramipril on ambulatory blood pressure: a multicenter trial.
    Burris JF
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S131-3. PubMed ID: 1725022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
    J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population.
    Shankar PK; Vidyasagar S; Adiga S; Naidu MU; Usha Rani P; Rao D; Bairy KL; Nair S; Jayaprakash B; Shashikiran U; Mukhyapranaprabhu
    Indian J Physiol Pharmacol; 2006; 50(4):421-6. PubMed ID: 17402274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring.
    Uchaipichat V; Koanantakul B; Suthisisang C
    J Med Assoc Thai; 2008 Sep; 91(9):1468-77. PubMed ID: 18843880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive efficacy, tolerance, and safety of long-term treatment with ramipril in patients with mild-to-moderate essential hypertension.
    Schreiner M; Berendes B; Verho M; Langley A; Cairns V
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S137-40. PubMed ID: 1725024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
    Ambühl PM; Tissot AC; Fulurija A; Maurer P; Nussberger J; Sabat R; Nief V; Schellekens C; Sladko K; Roubicek K; Pfister T; Rettenbacher M; Volk HD; Wagner F; Müller P; Jennings GT; Bachmann MF
    J Hypertens; 2007 Jan; 25(1):63-72. PubMed ID: 17143175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
    Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
    J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Severe hypoglycemia secondary to angiotensin-converting-enzyme inhibitors in the absence of diabetes mellitus. Report of a case].
    Elorriaga-Sánchez F; Corrales-Bobadilla H; Sosa-Trinidad E; Domínguez-Quezada B
    Gac Med Mex; 2001; 137(3):249-52. PubMed ID: 11432094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J; Vítovec J; Soucek M; Dusek L; Pavlík T;
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Ramipril and Isradipin on hemorheological profiles in patients with arterial hypertension.
    Muravyov AV; Zaitsev LG; Muravyov AA; Yakusevich VV; Sirotkina AM
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):185-90. PubMed ID: 9699040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of ramipril on sympathetic nervous system function in older patients with hypertension.
    Lee CC; Sidani MA; Hogikyan RV; Supiano MA
    Clin Pharmacol Ther; 1999 Apr; 65(4):420-7. PubMed ID: 10223780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beneficial effects of Hartil on cardiovascular remodeling process in elderly and old patients with isolated systolic arterial hypertension].
    Kiphshidze N; Zubiashvili T; Chagunava K
    Georgian Med News; 2008 Jan; (154):7-13. PubMed ID: 18323584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-response relationship of ramipril in patients with mild-to-moderate hypertension.
    Schnaper HW
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S128-30. PubMed ID: 1725021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheological changes in hypertensive patients treated with ramipril.
    Rosenson RS; Hafner JM
    Clin Hemorheol Microcirc; 1997; 17(1):41-6. PubMed ID: 9181757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerability of ramipril in a multicenter study of mild-to-moderate hypertension in general practice.
    Carré A; Vasmant D; Elmalem J; Thiéry P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S141-3. PubMed ID: 1725026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.